5
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP2101 |
Z-VRPR-FMK trifluoroacetate salt
|
||
Irreversible MALT1 inhibitor. Suppresses T cell activation-induced cleavage of Bcl-10 in a dose-dependent manor. Reduces Jurkat cell adhesion to fibronectin. Cell permeable. | |||
T73093 | Z-VRPR-FMK | ||
Z-VRPR-FMK 是一种不可逆地 MALT1蛋白抑制剂。Z-VRPR-FMK 可通过抑制 MALT1诱导的 NF-κB 活化和 MMP 表达来抑制弥漫性大 B 细胞淋巴瘤的生长和侵袭。 | |||
T75938 |
Z-VRPR-FMK TFA
|
||
Z-VRPR-FMK (TFA) (VRPR) 为一种四肽类选择性及不可逆的粘膜相关淋巴组织淋巴瘤易位蛋白1 (MALT1) 抑制剂,具有抵抗甲型流感病毒 (IAV) 感染的能力。 | |||
TP1014 |
Z-VRPR-FMK (TFA)
VRPR |
||
Z-VRPR-FMK (TFA) (VRPR) is a tetrapeptide and a selective and irreversible inhibitor of lymphoma translocation protein 1 (MALT1) in mucosa-associated lymphoid tissue. | |||
T80110 |
Ac-VRPR-AMC
|
Caspase | Apoptosis; Proteases/Proteasome |
Ac-VRPR-AMC为特异性荧光metacaspase底物,常用以测定metacaspase活性。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01007 |
VEGFC Protein, Human, Recombinant (His)
血管内皮生长因子,LMPH1D,VEGF-C,Flt4-L,vascular endothelial growth fa... |
Human | HEK293 Cells |
VEGFC Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 15.5 kDa and the accession number is P49767. | |||
TMPK-01043 |
VEGFC Protein, Human, Recombinant (His & Avi)
Flt4-L,血管内皮生长因子,VEGFC,VRP,VEGF-C |
Human | HEK293 Cells |
the lymphangiogenic factors vascular endothelial growth factor C (VEGFC) and VEGFD are cleaved by thrombin and plasmin, serine proteases generated during hemostasis and wound healing. Genetic studies reveal that platelet enhancement of lymphatic growth after wounding is dependent on the release of VEGFC, but not VEGFD, a finding consistent with high expression of VEGFC in both platelets and avian thrombocytes. VEGFC Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells w... | |||
TMPK-01044 |
VEGFC Protein, Human, Recombinant (His & Avi), Biotinylated
血管内皮生长因子,Flt4-L,VRP,VEGF-C,VEGFC |
Human | HEK293 Cells |
the lymphangiogenic factors vascular endothelial growth factor C (VEGFC) and VEGFD are cleaved by thrombin and plasmin, serine proteases generated during hemostasis and wound healing. Genetic studies reveal that platelet enhancement of lymphatic growth after wounding is dependent on the release of VEGFC, but not VEGFD, a finding consistent with high expression of VEGFC in both platelets and avian thrombocytes. VEGFC Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mam... |